Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL)

NCT00983138 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoid Leukemia

Interventions

DRUG: recombinant asparaginase

Sponsor

medac GmbH